Toxicological and Pathological Applications of Proliferating Cell Nuclear Antigen (PCNA), A Novel Endogenous Marker for Cell Proliferation

References

• Miyachi K., Fritzler M. J., Tan E. M. Autoantibody to a nuclear antigen in proliferating cells. J. Immunol. 1978; 121(6)2228
   PubMedGoogle Scholar
• Doolittle D. J., McKarns S. C., Ayres P. H., Bombick D. W. Molecular approaches for quantifying DNA synthesis and cell proliferation during rodent bioassays. Toxicol. Methods 1991; 1(4)215
   Google Scholar
• Ogata K., Kurki P., Celis E. J., Nakamura R. M., Tan E. M. Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp. Cell. Res. 1987; 168: 475
   PubMed Web of Science ®Google Scholar
• Almendral J. M., Heubsch D., Blundell P. A., MacDonald‐Bravo H., Bravo R. Cloning and sequence of the human nuclear protein cyclin: Homology with DNA‐binding proteins. Proc. Natl. Acad. Sci. USA 1987; 84: 1575
   PubMed Web of Science ®Google Scholar
• Moriuchi T., Matsumoto K., Koji T., Nakane P. K. Molecular cloning and nucleotide sequence analysis of rat PCNA/cyclin cDNA. Nucleic Acids Res. 1986; 17: 117
   Google Scholar
• Matsumoto K., Moriuchi T., Koji T., Nakane P. K. Molecular cloning of cDNA coding for rat proliferating cell nuclear antigen (PCNA/cyclin). EMBO J. 1987; 6(3)637
   PubMedGoogle Scholar
• Zuber M., Tan E. M., Ryoji M. Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Mol. Cell. Biol. 1989; 9(1)57
   PubMedGoogle Scholar
• Zuber M., Yasui W., Tan E. M., Ryoji M. Quantitation and subcellular localization of proliferating cell nuclear antigen (PCNA) in oocytes and eggs ofXenopus laevis. Exp. Cell Res. 1989; 182: 384
   PubMedGoogle Scholar
• Celis J. E., Madsen P., Celis A., Nielsen H. V., Gesser B. Cyclin (PCNA, auxiliary protein of DNA polymerase δ) is a central component of the pathway(s) leading to DNA replication and cell division. FEBS Lett. 1987; 220(1)1
   PubMedGoogle Scholar
• Yamaguchi M., Nishida Y., Moriuchi T., Hirose F., Hui C., Suzuki Y., Matsutake A. Drosophila proliferating cell nuclear antigen (cyclin) gene: structure, expression during development, and specific binding of homeodomain proteins to its 5′‐flanking region. Mol. Cell. Biol. 1990; 10(3)872
   PubMedGoogle Scholar
• Olins D. E., Olins A. L., Cacheiro L. H., Tan E. M. Proliferating cell nulcear antigen/cyclin in ciliateEuplotes eurystemus: localization in the replication band and micronuclei. J. Cell Biol. 1989; 109: 1399
   PubMed Web of Science ®Google Scholar
• Suzuka I., Daidoji H., Matsuoka M., Kadowaki K., Takasaki Y., Nakane P. K., Moriuchi T. Gene for proliferating cell nuclear antigen (DNA polymerase δ auxiliary protein) is present in both mammalian and higher plant genomes. Proc. Natl. Acad. Sci. USA 1989; 86: 3189
   PubMed Web of Science ®Google Scholar
• Bauer G. A., Burger P. M. J. The yeast analog of mammalian cyclin/proliferating cell nuclear antigen interacts with mammalian DNA polymerase 5. Proc. Natl. Acad. Sci. USA 1988; 85: 7506
   PubMed Web of Science ®Google Scholar
• O'Reilly D. R., Crawford A. M., Miller L. K. Viral proliferating cell nuclear antigen. Nature 1989; 337: 606
   PubMedGoogle Scholar
• Hori H., Osawa S. Evolutionary change in 5S RNA secondary structure and a phylogenic tree of 54 5S RNA species. Proc. Natl. Acad. Sci. USA 1979; 76(1)381
   PubMedGoogle Scholar
• Kimura M., Ohta T. On some principles governing molecular evolution. Proc. Natl. Acad. Sci. USA 1974; 71(7)2848
   PubMedGoogle Scholar
• Yamaguchi M., Hayashi Y., Hirose F., Matsuka S., Moriuchi T., Shiroishi T., Moriwaki K., Matsukage A. Molecular cloning and structural analysis of mouse gene and pseudogenes for proliferating cell nuclear antigen. Nucleic Acids Res. 1991; 19(9)2403
   PubMedGoogle Scholar
• Kosugi S., Suzuka I., Ohashi Y., Marakami T., Arai Y. Upstream sequences of rice proliferating cell nuclear antigen (PCNA) gene mediate expression of PCNA‐GUS chimeric gene in meristems of transgenic tobacco plants. Nucleic Acids Res. 1991; 19(7)1571
   PubMedGoogle Scholar
• Desplan C., Theis J., O'Farrell P. H. The sequence specificity of homeodomain‐DNA interaction. Cell 1988; 54: 1081
   PubMed Web of Science ®Google Scholar
• Chowdhury K., Deutsch U., Gruss P. A multigene family encoding several “finger” structures is present and differentially active in mammalian genomes. Cell 1987; 48: 771
   PubMed Web of Science ®Google Scholar
• Travali S., Ku D. ‐H., Rizzo M. ‐G., Ottavio L., Baserga R., Calabretta B. Structure of the human gene for the proliferating cell nuclear antigen. J. Biol. Chem. 1989; 264(13)7466
   PubMedGoogle Scholar
• Ottavio L., Chang C. ‐D., Rizzo M. ‐G., Travali S., Casadevali C., Baserga R. Importance of introns in the growth regulation of mRNA level of the proliferating cell nuclear antigen. Mol. Cell. Biol. 1990; 10(1)303
   PubMedGoogle Scholar
• Takasaki Y., Fishwild D., Tan E. M. Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J. Exp. Med. 1984; 159: 981
   PubMed Web of Science ®Google Scholar
• Laughon A., Scott M. P. Sequence of aDrosophila segmentation gene: protein structure homology with DNA‐binding proteins. Nature 1984; 310: 25
   PubMedGoogle Scholar
• Tan C. ‐K., Castillo C., So A. G., Downey K. M. An auxiliary protein for DNA polymerase δ from fetal calf thymus. J. Biol. Chem. 1986; 261(26)12310
   PubMedGoogle Scholar
• Ogata K., Celis J. E., Tan E. M. Proliferating cell nuclear antigen: cyclin. Methods Enzymol. 1987; 150: 147
   PubMed Web of Science ®Google Scholar
• Celis J. E., Bravo R., Larsen P. M., Fey S. Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leukemia Res. 1984; 8(2)143
   PubMed Web of Science ®Google Scholar
• Bravo R., Frey S. J., Bellantin J., Larsen P. M., Arevalo J., Celis J. E. Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation, Exp. Cell. Res. 1981; 136: 311
   Google Scholar
• Mathews M. B., Bernstein R. M., Franza B. R., Garrels J. I. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984; 309: 374
   PubMed Web of Science ®Google Scholar
• Sadaie M. R., Mathews M. B. Immunochemical and biochemical analysis of the proliferating cell nuclear antigen (PCNA) in HeLa cells. Exp. Cell. Res. 1986; 163: 423
   PubMed Web of Science ®Google Scholar
• Smart J. E., Lewis J. B., Mathews M. B., Harter M. L., Anderson C. W. Adenovirus type 2 early proteins: assignment of the early region 1A proteins synthesized in vivo and in vitro to specific mRNAs. Virology 1981; 112: 703
   PubMedGoogle Scholar
• Persson H., Hennighausen L., Taub R., DeGrado W., Leder P. Antibodies to human c‐myc oncogene product: evidence of an evolutionary conserved protein induced during cell proliferation. Science 1984; 225: 687
   PubMedGoogle Scholar
• Prelich G., Kostura M., Marshak D. R., Mathews M. B., Stillman B. The cell‐cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature 1987; 326: 471
   PubMed Web of Science ®Google Scholar
• Bauer G. A., Burgers P. M. J. Molecular cloning, structure and expression of the yeast proliferating cell nuclear antigen gene. Nucleic Acids Res. 1990; 18(2)261
   PubMedGoogle Scholar
• Bravo R., MacDonald‐Bravo H. Changes in the nuclear distribution of cylin (PCNA) but not its synthesis depend on DNA replication. EMBO J. 1985; 4(3)655
   PubMedGoogle Scholar
• Bravo R., MacDonald‐Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J. Cell Biol. 1987; 105: 1549
   PubMed Web of Science ®Google Scholar
• Celis J. E., Fey S. J., Larsen P. M., Celis A. Expression of the transformation‐sensitive protein “cyclin” in normal human epidermal basal cells and simian virus 40‐transformed keratinocytes. Proc. Natl. Acad. Sci. USA 1984; 81: 3128
   PubMed Web of Science ®Google Scholar
• Celis J. E., Celis A. Cell cycle‐dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc. Natl. Acad. Sci. USA 1985; 82: 3262
   PubMed Web of Science ®Google Scholar
• Celis J. E., Madsen P. Increased nuclear cy‐clin/PCNA antigen staining of non S‐phase transformed human amnion cells engaged in nucleotide excision DNA repair. FEBS Lett. 1986; 209(2)277
   PubMedGoogle Scholar
• Kurki P., Vanderlaan M., Dolbeare F., Gray J., Tan E. M. Expression of proliferating cell nuclear antigen (PCNA/cyclin) during the cell cycle. Exp. Cell. Res. 1986; 166: 209
   PubMed Web of Science ®Google Scholar
• Kurki P., Ogata K., Tan E. M. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA/cyclin) as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J. Immunol. Methods. 1988; 109: 49
   PubMed Web of Science ®Google Scholar
• Jaskulski D., Gatti C., Travali S., Calabretta B., Baserga R. Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J. Biol. Chern. 1988; 263(21)10175
   PubMedGoogle Scholar
• Kurki P., Lotz M., Ogata K., Tan E. M. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J. Immunol. 1987; 138(12)4114
   PubMedGoogle Scholar
• Morris G. F., Mathews M. B. Regulation of proliferating cell nuclear antigen during the cell cycle. J. Biol. Chem. 1989; 264(23)13856
   PubMed Web of Science ®Google Scholar
• Hall P. A., Levinson D. A., Woods A. L., Yu C. C.‐W., Kellock D. B., Watkins J. A., Barnes D. M., Gillett C. E., Camplejohn R., Dover R., Waseent N. H., Lane D. P. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol 1990; 162: 285
   PubMed Web of Science ®Google Scholar
• Ogata K., Ogata Y., Takasaki Y., Tan E. M. Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody. J. Immunol. 1987; 139(9)2942
   PubMedGoogle Scholar
• Ogata K., Ogata Y., Nakamura R. M., Tan E. M. Purification and N‐terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti‐PCNA antibodies. J. Immunol. 1985; 135(4)2623
   PubMedGoogle Scholar
• Waseem N. H., Lane D. P. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): structural conservation and the detection of a nucleolar form. J. Cell Sci. 1990; 96: 121
   PubMed Web of Science ®Google Scholar
• Richter F., Richter A., Yang K., Lipkin M. Cell proliferation in rat colon measured with BrdU, PCNA, and ‘3H’dThd. Proc. Am. Assoc. Cancer Res. 1991; 32: 154
   Google Scholar
• Galand P., Degraef C. Cyclin/PCNA immunostaining as an alternative to triated thymidine pulse labeling for marking S‐phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet. 1989; 22: 383
   PubMedGoogle Scholar
• Coltrera M. D., Gown A. M. PCNA/Cyclin expression and BrdU uptake define different sub‐populations in different cell lines. J. Histochem. Cytochem. 1991; 39(1)23
   PubMedGoogle Scholar
• Baserga R. Growth regulation of the PCNA gene. J. Cell Sci. 1991; 98: 433
   PubMed Web of Science ®Google Scholar
• Chang C. ‐D., Ottavio L., Travali S., Lipson K., Baserga R. Transcriptional and posttranscriptional regulation of the proliferating cell nuclear antigen gene. Mol. Cell. Biol. 1990; 10(7)3289
   PubMedGoogle Scholar
• Liu Y. ‐C., Bambara R. A. Gene expression of PCNA/cyclin in adult tissues and the R3230AC mammary tumor of the rat. Biochem. Biophys. Res. Commun. 1989; 161(2)873
   PubMedGoogle Scholar
• Wong R. L., Katz M. E., Ogata K., Tan E. M., Cohen S. Inhibition of nuclear DNA synthesis by an autoantibody to proliferating cell nuclear an‐tigen/cyclin. Cell. Immunol. 1987; 110: 443
   PubMed Web of Science ®Google Scholar
• Jaskulski D., de Riel J. K., Mercer W. E., Calabretta B., Baserga R. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA/cyclin. Science 1988; 240: 1544
   PubMed Web of Science ®Google Scholar
• Bravo R., Frank R., Blundell P. A., MacDonald‐Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase δ. Nature 1987; 326: 515
   PubMed Web of Science ®Google Scholar
• Prelich G., Tan C. ‐K., Kostura M., Mathews M. B., So A. G., Downey K. M., Stillman B. Functional identity of proliferating cell nuclear antigen and DNA polymerase δ auxiliary protein. Nature 1987; 326: 517
   PubMed Web of Science ®Google Scholar
• Wolds M. S., Li J. J., Weinberg D. H., Virshup D. M., Sherley J. L., Verheyen E., Kelly T. Cellular proteins required for SV40 DNA replication in vitro. Cancer Cells 1988; 6: 133
   Google Scholar
• Fairman M. P. DNA polymerase δ/PCNA: actions and interactions. J. Cell Sci. 1990; 95: 1
   PubMed Web of Science ®Google Scholar
• Downey K. M., Tan C. ‐K., Andrews D. M., Li X., So A. G. Proposed roles for DNA polymerases α and δ at the replication fork. Cancer Cells 1988; 6: 403
   Google Scholar
• So A. G., Downey K. M. Mammalian DNA polymerases α and δ: current status in DNA replication. Biochemistry 1988; 27(13)4591
   PubMedGoogle Scholar
• Stillman B. Initiation of eukaryotic DNA replication in vitro. BioEssays 1988; 9: 56
   PubMedGoogle Scholar
• Prelich G., Stillman B. Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 1988; 53: 117
   PubMed Web of Science ®Google Scholar
• Tsurimoto T., Stillman B. Replication factors required for SV40 DNA replication in vitro. I. J. Biol. Chem. 1991; 266(3)1950
   PubMedGoogle Scholar
• Tsurimoto T., Stillman B. Replication factors required for SV40 DNA replication in vitro. II. J. Biol. Chem. 1991; 266(3)1961
   PubMedGoogle Scholar
• Melendy T., Stillman B. Purification of DNA polymerase δ as an essential simian virus 40 DNA replication factor. J. Biol. Chem. 1991; 266(3)1942
   PubMedGoogle Scholar
• Lee S. ‐H., Kwong A. D., Pan Z. ‐Q., Hurwitz J. Studies on the activator 1 protein complex, an accessory factor for proliferating cell nuclear antigen‐dependent polymerase δ. J. Biol. Chem. 1991; 266(1)549
   Google Scholar
• Toschi L., Bravo R. Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J. Cell Biol. 1988; 107: 1623
   PubMedGoogle Scholar
• Shivji M. K. K., Kenny M. K., Wood R. D. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992; 69: 367
   PubMed Web of Science ®Google Scholar
• Coverley D., Kenny M. K., Lane D. P., Wood R. D. A role for the human single‐stranded DNA binding protein HSSB/RPA in an early stage of nucleotide excision repair. Nucleic Acids Res. 1992; 20(15)3873
   PubMedGoogle Scholar
• Syvaoja J., Linn S. Characterization of a large form of DNA polymerase δ from HeLa cells that is insensitive to proliferating cell nuclear antigen. J. Biol. Chem. 1989; 264(5)2489
   PubMedGoogle Scholar
• Nishida C., Reinhard P., Linn S. DNA repair synthesis in human fibroblasts requires DNA polymerase δ. J. Biol. Chem. 1989; 263(1)501
   Google Scholar
• del Giglio A., Khetan R., Saya H., Johnston D., Hester J., El‐Naggar A., Deisseroth A. High levels of PCNA in adult acute myelogenous leukemia (AML) are associated to increased resistance to chemotherapy and not to cell proliferation. Proc. Am. Assoc. Cancer Res. 1992; 33: 1589
   Google Scholar
• Finlay C. A., Hinds P. W., Levine A. J. The p53 proto‐oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083
   PubMed Web of Science ®Google Scholar
• Mercer W. E., Shields M. T., Amin M., Sauve G. J., Appelia E., Romano J. W., Ullrich S. J. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild‐type p53. Proc. Natl. Acad. Sci. USA 1990; 87: 6166
   PubMed Web of Science ®Google Scholar
• Levine A. J., Momad J., Finlay C. A. The p53 tumor suppressor gene. Nature 1991; 351: 453
   PubMed Web of Science ®Google Scholar
• Marshall D. J. Tumor suppressor genes. Cell 1991; 64: 313
   PubMed Web of Science ®Google Scholar
• Harlow E. For our eyes only. Nature 1992; 359: 270
   PubMed Web of Science ®Google Scholar
• Buchkovich K., Duffy L. A., Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 59: 1097
   Google Scholar
• Mihara K., Cao X. ‐R., Yen A., Chandler S., Discroll B., Murphree L., T'Ang A., Fung Y. ‐K. T. Cell cycle‐dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 1989; 246: 1300
   PubMed Web of Science ®Google Scholar
• DeCaprio J. A., Ludlow J. W., Lynch D., Furukawa Y., Griffin J., Piwnica‐Worms H., Huang C. ‐M., Livingston D. M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58: 1085
   PubMed Web of Science ®Google Scholar
• Chen P. ‐L., Scully P., Shew J. ‐Y., Wang J. Y. J., Lee W. ‐H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58: 1193
   PubMed Web of Science ®Google Scholar
• Bischoff J. R., Friedman P. N., Marshak D. R., Prives C., Beach D. Human p53 is phosphorylated by p60‐cdc2 and cyclin B‐cdc2. Proc. Natl. Acad. Sci. USA 1990; 87: 4766
   PubMed Web of Science ®Google Scholar
• Hunter T., Pines J. Cyclins and cancer. Cell 1991; 66: 1071
   PubMed Web of Science ®Google Scholar
• Kern S. E., Kinzler K. W., Bruskin A., Jarosz D., Friedman P., Prives C., Vogelstein B. Identification of p53 as a sequence‐specific DNA‐binding protein. Science 1991; 252: 1078
   PubMedGoogle Scholar
• Fields S., Jang S. K. Presence of a potent transcription activating sequence in the p53 protein. Science 1990; 249: 1046
   PubMed Web of Science ®Google Scholar
• Raycroft L., Wu H., Lozano G. Transcriptional activation by wild‐type but not transforming mutants of the p53 anti‐oncogene. Science 1990; 249: 1049
   PubMed Web of Science ®Google Scholar
• Lee W. ‐H., Shew J. ‐S., Hong F. D., Sery T. W., Donoso L. A., Young L. ‐J., Bookstein R., Lee E. Y.‐H. P. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987; 329: 642
   PubMed Web of Science ®Google Scholar
• Mercer W. E., Shields M. T., Lin D., Appelia E., Ullrich S. J. Growth suppression induced by wild‐type p53 protein is accompanied by selective down‐regulation of proliferating cell nuclear antigen expression. Proc. Natl. Acad. Sci. USA 1991; 88: 1958
   PubMed Web of Science ®Google Scholar
• Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991; 51: 6304
   PubMed Web of Science ®Google Scholar
• Gannon J. V., Greaves R., Iggo R., Lane D. P. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 1990; 9(5)1595
   PubMed Web of Science ®Google Scholar
• Koniecki J., Nugent P., Kordowska J., Baserga R. Effect of the SV40 T antigen on the posttranscriptional regulation of the proliferating cell nuclear antigen and DNA polymerase‐α genes. Cancer, Res. 1991; 51: 1465
   PubMedGoogle Scholar
• Lane D. P., Crawford L. V. T antigen is bound to a host protein in SV 40‐transformed cells. Nature 1979; 278: 261
   PubMed Web of Science ®Google Scholar
• Horowitz J. M., Yandell D. W., Park S. ‐H., Canning S., Whyte P., Buchkovich K., Harlow E., Weinberg R. A., Dryja T. P. Point mutational inactivation of the retinoblastoma antioncogene. Science 1989; 243: 937
   PubMed Web of Science ®Google Scholar
• DeCaprio J. A., Ludlow J. W., Figge J., Shew J. ‐Y., Huang C. ‐M., Lee W. ‐H., Marsilio E., Paucha E., Livingston D. M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275
   PubMed Web of Science ®Google Scholar
• Pietenpol J. A., Holt J. T., Stein R. W., Moses H. L. Transforming growth factor β1 suppression of c‐myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. USA 1990; 87: 3758
   PubMed Web of Science ®Google Scholar
• Pietenpol J. A., Stein R. W., Moran E., Yaciuk P., Schlegel R., Lyons R. M., Pittelkow M. R., Münger K., Howley P. M., Moses H. L. TGF‐β1 inhibition of c‐myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 1990; 61: 777
   PubMed Web of Science ®Google Scholar
• Stanbridge E. J. Human tumor suppressor genes. Annu. Rev. Genet. 1990; 24: 615
   PubMed Web of Science ®Google Scholar
• Jelsma T. N., Howe J. A., Mymryk J. S., Evelegh C. M., Cunniff N. F. A., Bayley S. T. Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigen. Virology 1989; 171: 120
   PubMedGoogle Scholar
• Morris G. F., Mathews M. B. The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site. J. Virol. 1991; 65(12)6397
   PubMedGoogle Scholar
• Darmon E., Wargovich M. J. Immunohistochemical detection of p53 and PCNA overexpression in colorectal tumors. Proc. Am. Assoc. Cancer Res. 1992; 33: 1712
   Google Scholar
• Nicholas J., Cameron K. R., Honess R. W. Herpesvirus saimiri encodes homologues of G protein‐coupled receptors and cyclins. Nature 1992; 355: 362
   PubMed Web of Science ®Google Scholar
• Swenson K. I., Farrell K. M., Ruderman J. V. The clam embryo protein cyclin A induces entry into M phase and the resumption of meiosis inXenopus oocytes. Cell 1986; 47: 861
   PubMed Web of Science ®Google Scholar
• Dunphy W. G., Newport J. W. Unraveling of mitotic control mechanisms. Cell 1988; 55: 925
   PubMedGoogle Scholar
• Evans T., Rosenthal E. T., Youngblom J., Distel D., Hunt T. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 1983; 33: 389
   PubMed Web of Science ®Google Scholar
• Pines J., Hunt T. Molecular cloning and characterization of the mRNA for cyclin from sea urchin eggs. EMBO J. 1987; 6(10)2987
   PubMedGoogle Scholar
• Booher R., Beach D. Involvement of cdc 13 in mitotic control inSchizosaccharomyces pombe: possible interaction of the gene product with microtubules. EMBO J. 1988; 7(8)2321
   PubMedGoogle Scholar
• Solomon M., Booher R., Kirschner M., Beach D. Cyclin in fission yeast. Cell 1988; 54: 738
   PubMedGoogle Scholar
• Murray A. W., Kirschner M. W. Dominoes and clocks: the union of two views of the cell cycle. Science 1989; 246: 614
   PubMed Web of Science ®Google Scholar
• Pines J., Hunter T. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 1989; 58: 833
   PubMed Web of Science ®Google Scholar
• Lu X. P., Koch K. S., Lew D. J., Dulic V., Pines J., Reed S. I., Hunter T., Leffert H. L. Induction of cyclin mRNA and cyclin‐associated histone H1 kinase during liver regeneration. J. Ciol. Chem. 1992; 267(5)2841
   Google Scholar
• Murray A. W., Kirschner M. W. What controls the cell cycle?. Sci. Am. 1991; 264(3)34
   Google Scholar
• Girard F., Strausfeld U., Fernandez A., Lamb N. J. C. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 1991; 67: 1169
   PubMed Web of Science ®Google Scholar
• Devoto S. H., Mudryi M., Pines J., Hunter T., Nevins J. A cyclin A‐protein kinase complex possesses sequence‐specific DNA binding activity: p33cdcK is a component of the E2F‐cyclin A complex. Cell 1992; 68: 167
   PubMed Web of Science ®Google Scholar
• Ames B. N., Profet M., Gold L. S. Nature's chemicals and synthetic chemicals: comparative toxicology. Proc. Natl. Acad. Sci. USA 1990; 87: 7782
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Leubeck G. Two‐event model carcinogenesis: biological, mathematical, and statistical considerations. Risk Anal. 1990; 10(2)323
   PubMedGoogle Scholar
• Cohen S. M., Ellwein L. B. Cell proliferation in carcinogenesis. Science 1990; 249: 1007
   PubMed Web of Science ®Google Scholar
• Goldsworthy T. L., Butterworth B. E., Maronpot R. R. Concepts, labeling procedures, and design of cell proliferation studies relating to carcinogenesis. Environ. Health Perspect.
   Google Scholar
• Dietrich D. R., Swenberg J. A. The presence of α2μ globulin is necessary for d‐limonene promotion of male rat kidney tumors. Cancer Res. 1991; 51: 3512
   PubMed Web of Science ®Google Scholar
• Dietrich D. R., Swenberg J. A. Preneoplastic lesions in rodent kidney induced spontaneously or by non‐genotoxic agents: predictive nature and comparison to lesions induced by genotoxic carcinogens. Mutat. Res. 1991; 248: 239
   PubMedGoogle Scholar
• Slaga T. Cellular proliferation in multistage carcinogenesis. Proc. Int. Symp. Cell Proliferation and Chemical Carcinogenesis. January, 14–161992. NIEHS
   Google Scholar
• Takasaki Y., Deng J. ‐S., Tan E. M. A nuclear antigen associated with cell proliferation and blast transformation. J. Exp. Med. 1981; 154: 1899
   PubMed Web of Science ®Google Scholar
• Takasaki Y., Robinson W. A., Tan E. M. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia. J. Natl. Cancer Inst. 1984; 73(3)655
   PubMedGoogle Scholar
• Foley J. F., Tuck P. D., Ton T. ‐V. T., Frost M., Kari F., Anderson M. W., Maronpot R. R. Inhalation exposure to a hepatocarcinogenic concentration of methylene chloride does not induce sustained replicative DNA synthesis in hepatocytes of female B6C3F1 mice. Environ. Health Perspect.
   Google Scholar
• Dietrich D. R., Candrian R., Marsman D. S., Popp J. A., Kaufmann W. K., Swenberg J. A., in preparation
   Google Scholar
• Greenwell A., Foley J. F., Maronpot R. R. An enhanced method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett. 1991; 59: 251
   PubMed Web of Science ®Google Scholar
• Foley J. F., Dietrich D. R., Swenberg J. A., Maronpot R. R. Detection and evaluation of proliferating cell nuclear antigen (PCNA) in rat tissue by an improved immunohistochemical procedure. J. Histotechnol. 1991; 14(4)237
   Web of Science ®Google Scholar
• Robbins B. A., de la Vega D., Ogata K., Tan E. M., Nakamura R. M. Immunohistochemical detection of proliferating cell nuclear antigen in solid malignancies. Arch. Pathol. Lab. Med. 1987; 111: 841
   PubMed Web of Science ®Google Scholar
• Garcia R. L., Coltrera M. D., Gown A. M. Analysis of proliferative grade using anti‐PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am. J. Pathol. 1989; 134: 733
   PubMed Web of Science ®Google Scholar
• Thaete L. G., Ahnen D. J., Malkinson A. M. Proliferating cell nuclear antigen (PCNA/cyclin) immunocytochemistry as a labeling index in mouse lung tissues. Cell Tissue Res. 1989; 256: 167
   PubMed Web of Science ®Google Scholar
• Dietrich D. R., Marsman D. S., Popp J. A., Swenberg J. A. Retrospecitve assessment of liver cell proliferation: Comparison of two proliferation markers, PCNA and tritated thymidine. Toxicologist 1992; 12: 1007
   Google Scholar
• Dietrich D. R., Curtis L. R., unpublished results
   Google Scholar
• Woosley J. T., Dietrich D. R. J. Cutan. Pathol.
   Google Scholar
• Woosley J. T., Dietrich D. R. Prognostic significance of PCNA grade in malignant melanoma. J. Cutan. Pathol. 1992; 19: 557
   Google Scholar
• Takahashi H., Strutton G. M., Parsons P. G. Determination of proliferating fractions in malignant melanomas by anti‐PCNA/cyclin monoclonal antibody. Histopathology 1991; 18: 221
   PubMed Web of Science ®Google Scholar
• van Dierendonck J. H., Wijsman J. H., Keijzer R., van de Velde C. J. H., Cornelisse C. J. Cell‐cycle related staining patterns of anti‐proliferating cell nuclear antigen monoclonal antibodies. Am. J. Pathol. 1991; 138(5)1165
   PubMedGoogle Scholar
• Rowlands D. C., Brown H. E., Barber P. C., Jones E. L. The effect of tissue fixation on immunostaining for proliferating cell nuclear antigen with the monoclonal antibody PC10. J. Pathol. 1991; 165: 356
   PubMed Web of Science ®Google Scholar
• Foley J., Ton T., Maronpot R. R., Butterworth B., Goldsworthy T. L. Proliferating cell nuclear antigen (PCNA): comparison to tritiated thymidine (‘3H’‐Tdr) as a marker of proliferating hepatocytes in rats. Environ. Health Perspect.
   Google Scholar
• Nakamura J., Dietrich D. R., Swenberg J. A. Age‐related changes in cell proliferation in rat liver and kidney. Toxicologist 1992; 12: 1014
   Google Scholar
• Nakamura J., Dietrich D. R., Schoonhaven R., Swenberg J. A., In preparation
   Google Scholar
• Shi S. ‐R., Key M. E., Kalra K. L. Antigen retrieval in formalin‐fixed, paraffin‐embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 1991; 39(6)741
   PubMed Web of Science ®Google Scholar
• Yu C. C.‐W., Hall P. A., Fletcher C. D. M., Camplejohn R. S., Waseem N. H. W., Lane D. P., Levison D. A. Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology 1991; 19: 29
   PubMed Web of Science ®Google Scholar
• Greenwell A., Foley J. F., Maronpot R. R. Proliferating cell nuclear antigen immunohistochemistry: an enhanced method for archival rodent tissue. Toxicologist 1992; 12: 1008
   Google Scholar
• Maier P., Schawalder H., Eisner J. Single cell analysis in toxicity testing: the mitogenic activity of thioacetamide in cultured rat hepatocytes analyzed by DNA/protein flow cytometry. Arch. Toxicol. 1991; 65: 454
   PubMedGoogle Scholar
• Maier P., Kränzlin R., Fasciati R. Identification and characterization of aneuploidy‐inducing agents by DNA‐protein flow cytometry in V79 Chinese hamster cells. Toxicol. Methods
   Google Scholar
• Styles J. Measurement of ploidy and cell proliferation in the rodent liver. Proc. Int. Symp. Cell Proliferation and Chemical Carcinogenesis. January, 14–161992. NIEHS
   Google Scholar
• Hall P. A., Levison D. A. Review: assessment of cell proliferation in histological material. J. Clin. Pathol. 1990; 43: 184
   PubMed Web of Science ®Google Scholar
• Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A. Method for analysis of cellular DNA content of paraffin‐embedded pathological material using flow cytometry. J. Histochem. Cytochem. 1983; 31(11)1333
   PubMed Web of Science ®Google Scholar
• Hedley D. W. Flow cytometry using paraffin‐embedded tissue: five years on. Cytometry 1989; 10: 229
   PubMedGoogle Scholar
• Vindelov L. L., Christensen I. J., Nissen N. I. A detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3(5)323
   PubMedGoogle Scholar
• Woods A. L., Hall P. A., Shepherd N. A., Hanby A. M., Waseem N. H., Lane D. P., Levison D. A. The assessment of the proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991; 19: 21
   PubMed Web of Science ®Google Scholar
• Jain S., Filipe M. I., Hall P. A., Lane D. P., Levison D. A. Prognostic value of proliferating cell nuclear antigen in gastric carcinomas. J. Clin. Pathol. 1991; 44: 655
   PubMed Web of Science ®Google Scholar
• Kamel O. W., LeBran D. P., Davis R. E., Gerry G. J., Warnke R. A. Growth fraction estimation of malignant lymphomas in formalin‐fixed paraffin embedded tissue using anti‐PCNA/cyclin 19A2. Am. J. Pathol. 1991; 138(6)1472
   Google Scholar
• Scott R. J., Hall P. A., Haldane J. S., Van Noorden S., Price Y., Lane D. P., Wright N. A. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J. Pathol. 1991; 165: 173
   PubMed Web of Science ®Google Scholar
• Sarraf C. E., McCormick C. S. F., Brown G. R., Price Y. E., Hall P. A., Lane D. P., Alison M. R. Proliferating cell nuclear antigen immuno‐localization in gastro‐intestinal epithelia. Digestion 1991; 50: 85
   PubMedGoogle Scholar
• Paganelli G. M., Biasco G., Santucci R., Brandi G., Di Febo G., Miglioli M., Barbara L. Labeling patterns of bromodeoxyuridine and PCNA in human rectal biopsies. Proc. Am. Assoc. Cancer Res. 1992; 33: 222
   Google Scholar
• Eldridge S. R., Lyght O., Butterworth B. E., Goldsworthy T. L. Comparison of proliferating cell nuclear antigen and bromodeoxyuridine for measurements of hepatocellular proliferation in mice and rats. Proc. Am. Assoc. Cancer Res. 1992; 33: 868
   Google Scholar
• Eldridge S. R., Butterworth B. E., Goldsworthy T. L. Proliferating cell nuclear antigen (PCNA): a marker for hepatocellular proliferation in rodents. Environ. Health Perspect.
   Google Scholar
• Louis D. N., Edgerton S., Thor A. D., Hedley‐Whyte E. T. Proliferating cell nuclear antigen and Ki‐67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol. 1991; 81: 675
   PubMed Web of Science ®Google Scholar
• Wilcox D. K., Bertram T. A. Colonic epithelial cell proliferation in a rat model of carcinogenesis induced by a nongenotoxin. Toxicologist 1992; 12: 1020
   Google Scholar
• Ahnen D. J., Yoshitake K., Kinoshita K., Brown W. Proliferating cell nuclear antigen expression is a relaible marker of the proliferative compartment in the rat colon. Gastroenterology 1987; 92: 1291
   Google Scholar
• Goldsworthy T. L., Dunn C. S., Popp J. A. Dose effects of bromodeoxyuridine (BrdU) on rodent hepatocyte proliferation measurements. Toxicologist 1992; 12: 265
   Google Scholar
• Weghorst C. M., Henneman J. R., Ward J. M. Dose response of hepatic and renal DNA synthetic rates to continuous exposure of bromideoxyuridine (BrdU) via slow‐release pellets or osmotic minipumps in male B6C3F1 mice. J. Histochem. Cytochem. 1991; 39: 177
   PubMedGoogle Scholar
• Hilsenbeck S. G., Clark G. M., McGuire W. L. Why do so many promising prognostic factors fail to pan out?. Proc. Am. Assoc. Cancer Res. 1992; 33: 1211
   Google Scholar
• Vilor M., Khalek Y., Sorrentino J., Brown M., Herrera L. Uptake of proliferating cell nuclear antigen as a prognostic factor in soft‐tissue sarcomas. Proc. Am. Assoc. Cancer Res. 1992; 33: 1210
   Google Scholar
• Thomas H., Nasim M. M., Sarraf C. E., Alison M. R., Lambert H. E., Price P. M. Quantitation of proliferation in ovarian cancer by proliferating cell nuclear antigen (PCNA) immunostaining. Proc. Am. Assoc. Cancer Res. 1992; 33: 1554
   Google Scholar
• Robins P., Jones C. J., Biggerstaff M., Lindahl T., Wood R. D. Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA. EMBO J. 1991; 10(12)3913
   PubMedGoogle Scholar
• Kawakita N., Seki S., Sakaguchi H., Yanai A., Kuroki T., Mizoguchi Y., Kobayashi K., Monna T. Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from varous liver diseases fixed in formaldehyde. Am. J. Pathol 1992; 140(2)513
   PubMed Web of Science ®Google Scholar
• Tereda T., Nakunama Y. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19–9 and DU‐PAN‐2 in hyperplastic, preneoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths. Virchows Arch. A Pathol. Anat. 1992; 420: 327
   Google Scholar
• Rao V. V. N. G., Schnittger S., Hansmann I. Chromosomal localization of the human proliferating cell nuclear antigen (PCNA) gene to or close to 20p12 by in situ hybridization. Cytogenet. Cell Genet. 1991; 56: 169
   PubMedGoogle Scholar
• Ku D. ‐H., Travali S., Calabretta B., Huebner K., Baserga R. Human gene for proliferating cell nuclear antigen has pseudogenes and localizes to chromosome 20. Somat. Cell Mol. Genet. 1989; 15(4)297
   PubMedGoogle Scholar
• Suzuka I., Hata S., Matsuoka M., Kosugi S., Hashimoto J. Highly conserved structure of proliferating cell nulcear antigen (DNA polymerase δ auxiliary protein) gene in plants. Eur. J. Biochem. 1991; 195: 571
   PubMedGoogle Scholar
• Kodama H., Ito M., Ohnishi N., Suzuka I., Komamine A. Molecular cloning of the gene for plant proliferating cell nuclear antigen and expression of this gene during the cell cycle in synchronized cultures ofCantharanthus roseus cells. Eur. J. Biochem. 1991; 197: 495
   PubMedGoogle Scholar
• Coverley D., Kenny M. K., Munn M., Rupp W. D., Lane D. P., Wood R. D. Requirement for the replication protein SSB in human DNA excision repair. Nature 1991; 349: 538
   PubMed Web of Science ®Google Scholar
• Huang J. ‐C, Svoboda D. L., Reardon J. T., Sancar A. Human nucleotide excision nuclease removes thymine dimers from DNA by incising the 22nd phosphodiester bond 5′ and the 6th phosphodiester bond 3′ to the photodimer. Proc. Natl. Acad. Sci. USA 1992; 89: 3664
   PubMed Web of Science ®Google Scholar
• Sarnow P., Ho Y. S., Williams J., Levine A. J. Adenovirus Elb‐58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 1982; 28: 387
   PubMed Web of Science ®Google Scholar
• Whyte P., Buchkovich K. J., Horowitz J. M., Friend S. H., Raybuck M., Weinberg R. A., Harlow E. Association between an oncogene and an anti‐oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124
   PubMed Web of Science ®Google Scholar
• Taya Y., Yasuda H., Kamijo M., Nakaya K., Nakamura Y., Ohba Y., Nishimura S. In vitro phosphorylation of the tumor suppressor gene Rb protein by mitosis‐specific histone H1 kinase. Biochem. Biophys. Res. Commun. 1989; 164(1)580
   PubMedGoogle Scholar
• Eliyahu D., Michalovitz D., Eliyahu S., Pinhasi‐Kimhi O., Oren M. Wild‐type p53 can inhibit oncogene‐mediated focus formation. Proc. Natl. Acad. Sci. USA 1989; 86: 8763
   PubMed Web of Science ®Google Scholar